Authors:
Kitazono, M
Robey, R
Zhan, ZR
Sarlis, NJ
Skarulis, MC
Aikou, T
Bates, S
Fojo, T
Citation: M. Kitazono et al., Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na+/I- symporter and iodine accumulationin poorly differentiated thyroid carcinoma cells, J CLIN END, 86(7), 2001, pp. 3430-3435
Citation: M. Kitazono et al., Construction of gene therapy vectors targeting thyroid cells: Enhancement of activity and specificity with histone deacetylase inhibitors and agents modulating the cyclic adenosine 3 ',5 '-monophosphate pathway and demonstration of activity in follicular and anaplastic thyroid carcinoma cells, J CLIN END, 86(2), 2001, pp. 834-840
Authors:
Kitazono, M
Goldsmith, ME
Aikou, T
Bates, S
Fojo, T
Citation: M. Kitazono et al., Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228, CANCER RES, 61(17), 2001, pp. 6328-6330
Authors:
Kitazono, M
Sumizawa, T
Takebayashi, Y
Chen, ZS
Furukawa, T
Nagayama, S
Tani, A
Takao, S
Aikou, T
Akiyama, S
Citation: M. Kitazono et al., Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells, J NAT CANC, 91(19), 1999, pp. 1647-1653
Authors:
Kitazono, M
Takebayashi, Y
Ishitsuka, K
Takao, S
Tani, A
Furukawa, T
Miyadera, K
Yamada, Y
Aikou, T
Akiyama, S
Citation: M. Kitazono et al., Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidinephosphorylase, BIOC BIOP R, 253(3), 1998, pp. 797-803